David E. Kemp, MD
- 14Articles
- 43.5KReads
- 2007–2016Active
- 72Collaborators
- 800Citations
About
David E. Kemp, MD, has authored 14 articles published between 2007 and 2016 focusing on clinical aspects of bipolar disorder, schizophrenia/schizoaffective disorders, major depressive disorder, suicide, and psychiatry. His work includes studies on pharmacologic treatments such as quetiapine, asenapine, olanzapine, risperidone, divalproex sodium, aripiprazole, and lithium, as well as investigations into metabolic effects, clinical predictors of treatment response, and comorbidities including anxiety and substance use disorders. He has frequently collaborated with Joseph R. Calabrese, Keming Gao, Stephen J. Ganocy, Robert L. Findling, and Bryan K. Tolliver.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
